All News

Shortly after the FDA announced it would permit the sale of genetic tests to consumers, an editorial contends that these tests will actually contribute to the deluge of low-value, wasteful medical services that the healthcare system should try to eliminate.

The Center for Science in the Public Interest released the letter proactively after the Trump administration has already eased rules for school lunches and delayed implementation of a labeling rule for restaurants.

The findings are the results of a collaborative study conducted at various cancer institutions across the United States, which evaluated the impact of following the 2012 American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors.

A key step of seamless integration of technology across a healthcare system involves the payment function. Both internal-facing and consumer facing systems should be embedded in the workflow.

Although a report from the Surgeon General has determined that the aerosol vapor from e-cigarettes contains harmful chemicals like nicotine, a survey of US adults indicates that some are skeptical or unsure about the risk posed to children exposed to the vapor.

A new study in this week’s Morbidity and Mortality Weekly Report finds that people with arthritis are more likely to limit their activities due to their symptoms if they live in a rural county, indicating the need to offer targeted interventions to this population.

Congress still has to reauthorize the Prescription Drug User Fee Act, and it can have big consequences for rare disease patients if there is a delay.

Although providers might turn to PCSK9 inhibitors to treat patients at risk for atherosclerotic cardiovascular disease or familial hypercholesterolemia for whom statins do not work, the initial denial rate for this therapy can be very high.

This week, the top managed care news included the Congressional Budget Office's new score for the American Health Care Act; the White House released its fiscal year 2018 budget; and a cancer drug approval that is a first for the FDA.

Based on the results of the phase 2 ZUMA-1 trial in patients with refractory non-Hodgkin lymphoma, Kite Pharma has submitted for, and received, a priority review for its chimeric antigen receptor (CAR)-T cell treatment, axicabtagene ciloleucel.

A new study published in Diabetes Care investigates ways to prevent driving accidents among patients with type 1 diabetes, who may be at higher risk of having such mishaps.

Few people have adequate savings for long-term care, and most assume they will care for relatives and rely on family for their own care. A survey from the Associated Press and the NORC Center for Public Affairs Research found support for family leave policies across members of both parties.

A panel discussion on biosimilars at the ISPOR 22nd Annual International Meeting compared the progress in the United States with Europe, which has had a 10-year head start on the market.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The Government Accountability Office has issued a report evaluating the continued public health response to the Zika virus in the US and detailing the remaining challenges and possible solutions.

Amy J. Reed, MD, died 4 years following her surgery that used a power morcellator to remove her uterus, resulting in the spread of a hidden cancer.

The American Medical Association declared obesity a disease in 2013, but insurers have been slow to cover drugs to treat the disease.

A Senate working group is already crafting an entirely new version of a replacement for the Affordable Care Act. House Speaker Paul Ryan waited on a new CBO score to make sure the American Health Care Act met necessary savings targets to use the budget reconciliation process to undo Obamacare.

Researchers from the University of Wisconsin devised a phone-based intervention to assist patients during the transition from hospital to home following complex abdominal surgery and reduce readmissions.

In the first weeks of his tenure as FDA commissioner, Scott Gottlieb, MD, is taking action on the issue he had vowed to make his “highest initial priority:” fighting the opioid abuse epidemic and stopping the waves of overdoses across the nation.

The proposed cuts would come just as CMS is gearing up to launch the Diabetes Prevention Program in Medicare starting in January 2018. Diabetes accounts for $1 of every $3 spent in Medicare, and CMS has been looking for ways to slow the number of beneficiaries who develop the disease.

The drug is now indicated for adult and pediatric patients with unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumors that lack suitable alternative treatments or that have progressed on treatment.

The researchers' hypothesis: improvements in continuous glucose monitoring technology would bring greater quality of life improvements for those with type 1 diabetes, even if they were not using insulin pumps.

A study published in the Annals of Internal Medicine reports that black Medicare enrollees are less likely to receive colonoscopy from more highly-rated physicians, which could increase their risk for interval colorectal cancer.

The recent global breach hit the United Kingdom's National Health Service especially hard. But outdated systems and a lack of updates made the incident predictable. Some simple steps could have reduced the risk.